MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Characteristics and Trends of Parkinson’s Disease Patients Receiving Deep Brain Stimulation: Insights From a US All-Payer Health Administrative Claims Database

    W. Zhang, M. Bharadwaz, A. Gabriel, J. Weber, M. Frick, A. Yaldo, C. Gøtzsche, T. Machewitz, J. Lott (Whippany, USA)

    Objective: To describe sociodemographics, treatment patterns, and costs among Parkinson’s patients who received deep brain stimulation (DBS) in the United States (US). Background: Parkinson’s disease…
  • 2025 International Congress

    Prevalence of Central Pain in Parkinson’s Disease: A Systematic Review and Meta-analysis

    K. Vieira, L. Pereira, G. Trevisan (Santa Maria, Brazil)

    Objective: In this systematic review and meta-analysis, we aimed to evaluate the prevalence of central pain and how this symptom may affect the patient's quality…
  • 2025 International Congress

    Exploring the ubiquitome in Parkinson’s Disease

    A. Yeung, SA. Cobbold, M. Li, GK. Smyth, L. Wang, JR. Han, IKL. Tan, M. Bahlo, AH. Evans, D. Komander, S. Masaldan, G. Dewson (Melbourne, Australia)

    Objective: To explore the role of ubiquitin signalling defects in Parkinson’s Disease. Background: Defects in ubiquitin signalling have been implicated in the pathogenesis of neurodegenerative…
  • 2025 International Congress

    Apolipoprotein E ɛ4-allele and Amygdala Atrophy in Parkinson’s Disease: A Preliminary Longitudinal Analysis from the ONDRI Cohort

    U. Saeed, R. Bartha, M. Binns, S. Black, D. Grimes, R. Hegele, C. Marras, . Rogaeva, M. Lang, M. Masellis (Toronto, Canada)

    Objective: To investigate the association of apolipoprotein E ɛ4-allele (APOE-ε4) with amygdala volumes longitudinally in Parkinson’s disease (PD). Background: APOE-ε4 is a genetic risk factor…
  • 2025 International Congress

    Contribution of Dopamine Depletion, Cerebral Perfusion, and Cognition to Gait Dysfunction in Parkinson’s Disease

    HK. Na, CW. Park, Y. Sun, JH. Lee, YY. Choi, SJ. Chung, YH. Sohn, CH. Lyoo, PH. Lee (Seodaemun-gu, Republic of Korea)

    Objective: To explore the potential contribution of dopamine loss, perfusion deficit, and cognition to spatiotemporal gait parameters in patients with Parkinson's disease (PD). Background: Gait…
  • 2025 International Congress

    Comparison of Microglial PET Imaging in Parkinson’s Disease, RBD, and Controls with a CSF1R and TSPO Ligand.

    K. Mills, I. Cheong, Y. Du, J. Coughlin, A. Horti, C. Motley, R. Dannals, W. Lesniak, T. Dawson, M. Pomper (Baltimore, USA)

    Objective: To compare regional binding patterns of microglial PET radioligands: [11C]DPA-713, a TSPO ligand, and [11C]CPPC1, a CSF1R ligand  in people with Parkinson’s disease (PD).…
  • 2025 International Congress

    Cerebello-Thalamo-Cortical Tract Microstructural Changes in Parkinson’s Disease Patients with Tremor

    I. Cruz, M. Wilken, G. álvarez, M. Villarreal, M. Merello (Buenos Aires, Argentina)

    Objective: To evaluate microstructural characteristics in the cerebello-thalamo-cortical circuit (CTC) of Parkinson's Disease (PD) patients with different tremor phenotypes. Background: Tremor is one of the…
  • 2025 International Congress

    Description Genotype/phenotype of patients with Parkinson’s disease. Report of an Argentinean cohort included in the LARGE PD Consortium.

    M. Espindola, N. Gonzalez Rojas, G. da Prat, M. Cesarini, J. Etcheverry, I. Mata, C. Perandones, E. Gatto (Cleveland, USA)

    Objective: To characterize the genetic and phenotypic profile of Argentinean Parkinson's patients and contribute to the understanding of the genetic heterogeneity of this disease. Background:…
  • 2025 International Congress

    Investigating the Global Genetic Spectrum of Monogenic Parkinson’s Disease and Parkinsonism

    L. Lange, M. Makarious, M. Avenali, S. Bardien, M. Doquenia, C. Galandra, P. Heutink, J. Junker, Y. Kanana, I. Keller Sarmiento, K. Kumar, H. Leonard, K. Levine, SY. Lim, K. Lohmann, N. Mencacci, M. Nalls, AH. Tan, J. Trinh, EM. Valente, C. Blauwendraat, S. Bandres-Ciga, A. Singleton, ZH. Fang, C. Klein (Bethesda, USA)

    Objective: To investigate known pathogenic and risk variants linked to Parkinson’s disease (PD) at a global, multi-ancestry scale. Background: Genetic forms of PD have been…
  • 2025 International Congress

    Non-motor Symptoms, Sleep Disturbances, And Genetic Insights In Young Onset Parkinson’s Disease: A Prospective Descriptive Study

    L. Sahoo, V. Choudhary, A. Mishra (Bhubaneswar, India)

    Objective: 1. To study the prevalence of various non-motor symptoms in Young onset Parkinson's Disease patients2. To study the genetic markers in YOPD patients. Background:…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley